2026 IPO Boom About Broadening Beyond AI Megadeals
The 2026 IPO boom is broadening beyond AI megadeals as mid-cap and overlooked sectors attract new capital. A busy sec...
Why price level matters is that it frames where supply and demand meet, shaping momentum and risk. Use this context to make smarter choices.
28,103 articlesThe 2026 IPO boom is broadening beyond AI megadeals as mid-cap and overlooked sectors attract new capital. A busy sec...
When conviction runs hot but capital is capped, traditional 1:1 bets may feel limiting. The forget returns: double-le...
President Trump unveils a White House pledge inviting hyperscalers to back on-site power generation to ease data cent...
A non-spouse beneficiary confronts roughly $120,000 in excess taxes after misinterpreting the SECURE Act 10-year rule...
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
AMD has surged in 2026 and is flirting with a $1 trillion market cap. This deep dive examines the drivers, risks, and...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
A wave of data center spending powered by AI is reshaping the investment landscape. This article explains which stock...
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
What happens when the urge to profit from other people’s drama collides with real-life costs? This article breaks dow...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...